Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123789022 | 12378902 | 2 | F | 201603 | 20160323 | 20160517 | 20160901 | EXP | US-RELYPSA-RLY2016000250 | RELYPSA | 92.00 | YR | M | Y | 0.00000 | 20160901 | OT | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123789022 | 12378902 | 1 | PS | VELTASSA | PATIROMER | 1 | Oral | 8.4 G, DAILY | 0 | 8.4 | G | ORAL SUSPENSION | |||||||
| 123789022 | 12378902 | 2 | C | CALCIUM /00060701/ | CALCIUM | 1 | 0 | ||||||||||||
| 123789022 | 12378902 | 3 | SS | BLOOD PRESSURE MEDICATION | UNSPECIFIED INGREDIENT | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123789022 | 12378902 | 1 | Hyperkalaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123789022 | 12378902 | Anal incontinence | |
| 123789022 | 12378902 | Constipation | |
| 123789022 | 12378902 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |